Introduction:

The COVID-19 is an infection of the respiratory tract caused by the SARS-CoV-2 that appears in patients with high risk factors as the metabolic syndrome.

Objective:

To update the knowledge on the clinical course and prognosis of patients with metabolic syndrome infected by the new coronavirus.

Development:

The secondary and tetiary sources consulted explain the direct relationship between the risk factors of the metabolic syndrome and the serious forms of the COVID-19, so that the clinical course and prognosis of these patients is very unfavorable, although the performance therapeutic protocols nowadays are considered complex and contextualized.

Conclusions:

The unfavorable clinical course of the patients with metabolic syndrome infected by the COVID-19 hides its prognosis, reason why the current therapeutic strategies for the care to these sick persons have not been able to stop the progressive course of the infectious disease identified in the metabolic comorbidity, that makes difficult the prevention of complications.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )